Medigus Ltd. Series C Warrant
MDGSW
MDGSW was delisted on the 19th of July, 2023.
4 hedge funds and large institutions have $44K invested in Medigus Ltd. Series C Warrant in 2020 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
68% less capital invested
Capital invested by funds: $137K → $44K (-$93K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.66K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$359 |
MDGSW Hedge Fund Activity: Q1 2020 in Review
4 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Medigus Ltd. Series C Warrant (MDGSW) for Q1 2020, worth a combined $44K — down 68% from $137K a quarter earlier.
Fund positioning in MDGSW was balanced in Q1 2020: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $2.66K. The largest seller was Sabby Management, cutting an estimated $359.
- 4 institutional investors held Medigus Ltd. Series C Warrant (MDGSW) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $44K of Medigus Ltd. Series C Warrant stock for Q1 2020, down 68% quarter-over-quarter.
- 0 funds opened new Medigus Ltd. Series C Warrant positions in Q1 2020 and 0 closed out.
- The largest Medigus Ltd. Series C Warrant buyer in Q1 2020 was Susquehanna International Group, an estimated $2.66K added.
- The largest Medigus Ltd. Series C Warrant seller in Q1 2020 was Sabby Management, an estimated $359 sold.
Based on aggregated 13F filings for Q1 2020.